![Therapeutic effects of cationic liposomes on lupus-prone MRL/lpr mice are mediated via inhibition of TLR4-triggered B-cell activation - ScienceDirect Therapeutic effects of cationic liposomes on lupus-prone MRL/lpr mice are mediated via inhibition of TLR4-triggered B-cell activation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1549963421001349-ga1.jpg)
Therapeutic effects of cationic liposomes on lupus-prone MRL/lpr mice are mediated via inhibition of TLR4-triggered B-cell activation - ScienceDirect
![Lupus-Prone Mice Resist Immune Regulation and Transplant Tolerance Induction - American Journal of Transplantation Lupus-Prone Mice Resist Immune Regulation and Transplant Tolerance Induction - American Journal of Transplantation](https://www.amjtransplant.org/cms/attachment/92b25083-ed8e-4330-87cb-a16986a8936e/gr3_lrg.jpg)
Lupus-Prone Mice Resist Immune Regulation and Transplant Tolerance Induction - American Journal of Transplantation
![Immunomodulatory effects of cytokine-induced expansion of cytotoxic lymphocytes in a mouse model of lupus-like disease - Cytotherapy Immunomodulatory effects of cytokine-induced expansion of cytotoxic lymphocytes in a mouse model of lupus-like disease - Cytotherapy](https://www.isct-cytotherapy.org/cms/attachment/49532c72-72c0-4eb2-99cc-3c63918c563b/fx1_lrg.jpg)
Immunomodulatory effects of cytokine-induced expansion of cytotoxic lymphocytes in a mouse model of lupus-like disease - Cytotherapy
![Lupus-prone (NZBxNZW)F 1 mice develop a severe and chronic skin disease... | Download Scientific Diagram Lupus-prone (NZBxNZW)F 1 mice develop a severe and chronic skin disease... | Download Scientific Diagram](https://www.researchgate.net/publication/49643408/figure/fig5/AS:667061017645061@1536051148223/Lupus-prone-NZBxNZWF-1-mice-develop-a-severe-and-chronic-skin-disease-resembling-human.png)
Lupus-prone (NZBxNZW)F 1 mice develop a severe and chronic skin disease... | Download Scientific Diagram
![Frontiers | (NZW × BXSB) F1 male mice: An unusual, severe and fatal mouse model of lupus erythematosus Frontiers | (NZW × BXSB) F1 male mice: An unusual, severe and fatal mouse model of lupus erythematosus](https://www.frontiersin.org/files/MyHome%20Article%20Library/977698/977698_Thumb_400.jpg)
Frontiers | (NZW × BXSB) F1 male mice: An unusual, severe and fatal mouse model of lupus erythematosus
![IJMS | Free Full-Text | Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation IJMS | Free Full-Text | Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation](https://www.mdpi.com/ijms/ijms-22-02291/article_deploy/html/images/ijms-22-02291-g001-550.jpg)
IJMS | Free Full-Text | Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation
![Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway | Lupus Science & Medicine Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway | Lupus Science & Medicine](https://lupus.bmj.com/content/lupusscimed/9/1/e000611/F2.large.jpg)
Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway | Lupus Science & Medicine
![Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice: Molecular Therapy - Methods & Clinical Development Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/db90a806-19bc-4d76-ac88-b33391d8badb/gr1.jpg)
Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice: Molecular Therapy - Methods & Clinical Development
![The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus- prone MRL/lpr mice | BMC Nephrology | Full Text The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus- prone MRL/lpr mice | BMC Nephrology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12882-019-1599-0/MediaObjects/12882_2019_1599_Fig1_HTML.png)
The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus- prone MRL/lpr mice | BMC Nephrology | Full Text
![Head-to-head comparative pharmacokinetic and biodistribution (PK/BD) study of two dexamethasone prodrug nanomedicines on lupus-prone NZB/WF1 mice - ScienceDirect Head-to-head comparative pharmacokinetic and biodistribution (PK/BD) study of two dexamethasone prodrug nanomedicines on lupus-prone NZB/WF1 mice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1549963420301209-ga1.jpg)
Head-to-head comparative pharmacokinetic and biodistribution (PK/BD) study of two dexamethasone prodrug nanomedicines on lupus-prone NZB/WF1 mice - ScienceDirect
![IJMS | Free Full-Text | Toll-like Receptor Signaling Inhibitory Peptide Improves Inflammation in Animal Model and Human Systemic Lupus Erythematosus IJMS | Free Full-Text | Toll-like Receptor Signaling Inhibitory Peptide Improves Inflammation in Animal Model and Human Systemic Lupus Erythematosus](https://www.mdpi.com/ijms/ijms-22-12764/article_deploy/html/images/ijms-22-12764-g001.png)
IJMS | Free Full-Text | Toll-like Receptor Signaling Inhibitory Peptide Improves Inflammation in Animal Model and Human Systemic Lupus Erythematosus
![Alpha 1 Antitrypsin Gene Therapy Extends the Lifespan of Lupus-Prone Mice: Molecular Therapy - Methods & Clinical Development Alpha 1 Antitrypsin Gene Therapy Extends the Lifespan of Lupus-Prone Mice: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/bb95ab43-37ab-4826-b9d0-5cfda3f5443d/gr1_lrg.jpg)
Alpha 1 Antitrypsin Gene Therapy Extends the Lifespan of Lupus-Prone Mice: Molecular Therapy - Methods & Clinical Development
![PD-1H (VISTA)–mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus | Science Translational Medicine PD-1H (VISTA)–mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aax1159/asset/c61f704b-9fb6-451e-8911-856131198686/assets/graphic/aax1159-f1.jpeg)
PD-1H (VISTA)–mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus | Science Translational Medicine
![Assessing Lupus‐Like Disease in Murine Model Systems - Lee - 2021 - Current Protocols - Wiley Online Library Assessing Lupus‐Like Disease in Murine Model Systems - Lee - 2021 - Current Protocols - Wiley Online Library](https://currentprotocols.onlinelibrary.wiley.com/cms/asset/f9f04690-226e-45e8-b25a-3de6cf80b8e0/cpz1272-fig-0005-m.jpg)
Assessing Lupus‐Like Disease in Murine Model Systems - Lee - 2021 - Current Protocols - Wiley Online Library
![Assessing Lupus‐Like Disease in Murine Model Systems - Lee - 2021 - Current Protocols - Wiley Online Library Assessing Lupus‐Like Disease in Murine Model Systems - Lee - 2021 - Current Protocols - Wiley Online Library](https://currentprotocols.onlinelibrary.wiley.com/cms/asset/7c40dd68-76b3-4140-9f17-371568315690/cpz1272-fig-0001-m.jpg)